Az els ő két sikeres, convalescens friss fagyasztott plazmával történő terápia hazai alkalmazása intenzív osztályon kezelt, kritikus állapotú, COVID-19-fertőzésben szenvedő betegekben.

CONCLUSIONS: Our experience indicates that convalescent plasma therapy is well tolerated and could potentially improve clinical outcomes. Optimal dose and timing as well as precise assessment of clinical benefit of convalescent plasma therapy will need further investigation in larger, well-controlled trials. This is the first report of the successful use of convalescent plasma in the treatment of critically ill patients with COVID-19 infection in Hungary. Orv Hetil. 2020; 161(27): 1111-1121.
PMID: 32564002 [PubMed - in process]

Source: Orvosi Hetilap - June 23, 2020 Category: General Medicine Authors: Bobek I, Gopcsa L, Réti M, Bekő G, Hancz L, Lakatos B, Molnár E, Nagy S, Reményi P, Sebestyén G, Sinkó J, Szlávik J, Szolnoky M, Vályi-Nagy I Tags: Orv Hetil Source Type: research